Secoo Receives Additional Delinquency Letter from Nasdaq Regarding Late Filing of Periodic Report on Form 6-K

Stock Information for Scopus BioPharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Scopus BioPharma Inc.

Secoo Receives Additional Delist Notice from Nasdaq
Secoo Receives Delisting Notice from Nasdaq and Plans to Request Hearing
Secoo Announces Receipt of Minimum Bid Price Notice from Nasdaq
Secoo Receives NASDAQ Notice Related to Late Filing of Form 20-F
Secoo Group: Officially Accesses OpenAI and ERNIE Bot, Luxury Goods Intelligent Marketing Scene Will Be More Accurate
SECOO Group: access to the ERNIE Bot developed by Baidu, the Chinese version of ChatGPT, luxury smart marketing scene landing for the first time
Secoo Group: Transforming Luxury Goods Operation Models with AIGC and ChatGPT Technologies
Secoo Reports Unaudited First Half 2022 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.